Exactmer
Exactmer is a UK deep tech spinout developing PLIMs polymer membranes for energy-efficient hydrocarbon separation and bio-based solvents for low-carbon pharmaceutical manufacturing, serving oil & gas and pharmaceutical enterprises through licensing and consortium partnerships.
- Company typePrivate
- Founded2018
- HeadquartersDagenham, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Exactmer does
Exactmer is a UK-based deep tech spinout, headquartered in Dagenham and founded in 2018, specializing in advanced polymer synthesis with two distinct product platforms. Its core technology is PLIMs (Polymer Membranes with Locked Intrinsic Microporosity), a new class of ultrathin polymer membranes that selectively separate complex hydrocarbon mixtures with up to 10x higher permeance than existing state-of-the-art membranes while maintaining high selectivity. In validated testing with Arabian Extra Light crude oil alongside SINOPEC, the technology achieved 99.8% heavy hydrocarbon removal and 93% reduction in sulphur-containing compounds, offering an energy-efficient alternative to conventional thermal distillation in oil refining.
The company is extending its polymer chemistry capabilities into a second platform: high purity bio-based solvents for pharmaceutical manufacturing, developed through a UK consortium funded by an Innovate UK grant of over £7 million, targeting at least 60% greenhouse gas emission reduction versus conventional solvent production. Exactmer operates a B2B licensing and co-development model, distributing technology through direct enterprise partnerships and consortium-based collaborations rather than traditional product sales channels. Its GTM motion is enterprise field sales targeting oil & gas and pharmaceutical manufacturing verticals, supported by roll-to-roll manufacturing demonstrated for industrial deployment.
Leadership combines academic research pedigree with emerging commercial discipline: co-founders Andrew Livingston (CEO) and Piers Gaffney (CSO) anchor the scientific platform, while Cristina Bertulli serves as VP of Business Development and Operations. The company is supported by multiple UK university research partnerships and has secured non-dilutive funding from both the EIC Accelerator and Innovate UK, positioning it as an early-stage but well-capitalized deep tech venture advancing sustainable industrial chemistry.
Exactmer firmographics
Firmographics- Name
- Exactmer
- Legal name
- Exactmer
- Website
- https://exactmer.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Exactmer is a UK deep tech spinout developing PLIMs polymer membranes for energy-efficient hydrocarbon separation and bio-based solvents for low-carbon pharmaceutical manufacturing, serving oil & gas and pharmaceutical enterprises through licensing and consortium partnerships.
- Ownership category
- akta.pro rank
Exactmer industry classification
Industry- Product category
- Industrial Membrane Technology
- NAICS
- Chemical Manufacturing (325), All Other Basic Organic Chemical Manufacturing (325199)
- SIC
- Industrial Organic Chemicals (2860), Miscellaneous Chemical Products (2890)
- akta.pro primary industry
- Bulk Industrial Solvents (IMAEAAAE)
- akta.pro secondary industry
- Bio-based Polymers & Resins (PLA, PHA, bio-PE, bio-PET, cellulose acetate) (IMAMALAC)
Keywords
Where Exactmer is headquartered
LocationHeadquarters
- HQ city
- Dagenham
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
Exactmer business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Revenue model
- Membrane Technology Licensing: Licensing of proprietary PLIMs membrane technology for hydrocarbon processing applications in oil & gas industry.
- Bio-based Solvents Technology: Technology development and industrialization of low-greenhouse gas solvents for pharmaceutical manufacturing through consortium partnerships.
Go-to-market motion1 record
Distribution channels1 record
Exactmer product offering
Product offeringCore offering
Exactmer develops and manufactures PLIMs (Polymer Membranes with Locked Intrinsic Microporosity), ultrathin polymer membranes for rapidly and selectively separating complex hydrocarbon mixtures as an energy-efficient alternative to thermal distillation in crude oil refining. The company is also industrializing high-purity bio-based solvents for pharmaceutical medicines manufacturing through a consortium-led program targeting substantial greenhouse gas emission reductions.
Product overview
Exactmer is a UK-based deep tech spinout offering two primary product lines: PLIMs (Polymer Membranes with Locked Intrinsic Microporosity) for energy-efficient hydrocarbon separation in crude oil refining, and high purity bio-based solvents for low-carbon medicines manufacturing. The PLIMs technology provides an alternative to conventional thermal distillation, while the solvents initiative targets significant greenhouse gas reduction in pharmaceutical production through a £7 million Innovate UK-funded consortium.
Differentiator
Problem solved
Functional benefit
Products and services
- PLIMs (Polymer Membranes with Locked Intrinsic Microporosity) Ultrathin polymer membranes with locked intrinsic microporosity capable of rapidly and selectively separating complex hydrocarbon mixtures. Demonstrated up to ten-fold higher permeance than state-of-the-art membranes while maintaining high selectivity, removing 99.8% of heavy hydrocarbons and reducing sulphur-containing compounds by 93%. Aimed at oil and gas companies engaged in crude oil refining and hydrocarbon processing.
- High Purity Bio-Based Solvents High purity bio-based solvents developed for medicines manufacturing, designed to reduce greenhouse gas emissions by at least 60% compared to conventional solvents. Being industrialized through a consortium of technology providers, pharmaceutical companies, and research organizations for use in pharmaceutical production.
Quantifiable outcome
- Up to 10x higher permeance than existing state-of-the-art membranes while maintaining high selectivity
- +3 more outcomes
Companies that use Exactmer
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Exactmer technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Exactmer partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- SINOPECcoreMajor Chinese petroleum corporation collaborating with Exactmer on development and testing of PLIMs membrane technology for hydrocarbon processing applications. SINOPEC participated in validation of membrane performance using Arabian Extra Light crude oil.
- UK UniversitiescoreMultiple UK universities collaborating with Exactmer on research and development of membrane technology for hydrocarbon separation. Universities provide research expertise and academic validation for the PLIMs technology development.
- UK Consortium Partners (Technology Providers, Pharmaceutical Companies, Research Organizations)coreTechnology providers, pharmaceutical companies, and research organizations working together under the Innovate UK-funded consortium to industrialize low-greenhouse gas solvents and validate their use in pharmaceutical production.
Scale indicators5 records
Recent moves5 records
Expansion highlights6 records
Exactmer competitors and assessment
Company assessmentEmerging players
- Porifera: US-based startup developing advanced thin-film composite membranes for industrial separations, including hydrocarbon and solvent applications. Closest direct emerging competitor to Exactmer's PLIMs membrane approach.
- Compact Membrane Systems: Developer of specialty membranes for chemical and petrochemical separations, including hydrocarbon processing. Comparable emerging player focused on membrane-based alternatives to distillation.
Direct peers
- Membrane Technology and Research (MTR): Pioneer in industrial membrane separations for hydrocarbons, gas, and petrochemical processing. Directly comparable as a membrane technology provider targeting refining and chemical industry customers.
Broad incumbents
- Pall Corporation: Danaher-owned industrial filtration and separations major serving oil & gas, chemicals, and pharma. Broad incumbent whose separation technology portfolio overlaps with Exactmer's hydrocarbon and solvent applications.
- Honeywell UOP: Global licensor of refining and petrochemical process technologies, including separation and upgrading units. Most likely acquirer profile and direct technology competitor for refinery-scale separation licenses.
- Evonik Industries: German specialty chemicals major with membrane and separation technology offerings (e.g., SEPURAN) and a strong bio-based and high-purity chemicals portfolio spanning pharma and industrial applications.
- BASF: World's largest chemical company with extensive solvents, bio-based intermediates, and process technology offerings for pharma and refining customers. Comparable broad incumbent and potential acquirer/partner for bio-based solvents.
- Solvay: Belgian specialty chemicals and advanced materials player with bio-based and high-purity solvent offerings serving pharma and industrial customers. Comparable in the bio-based solvents space.
- Axens: French licensor of refining and petrochemical process technologies, including separation and upgrading solutions. Comparable as a refining technology licensor and potential competitor/partner.
- DuPont: Major materials and specialty chemicals company with established membrane product lines (e.g., FilmTec, nanofiltration) and bio-based intermediates. Broad incumbent spanning membrane and specialty chemical markets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights7 records
Customer concentration
Exactmer social profiles
Digital presenceExactmer financial estimates
Financial estimateRevenue estimate
Valuation estimate
Exactmer leadership team
Management profileNumber of profiles
Profiles3 records
Exactmer funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Exactmer M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Exactmer
What does Exactmer do?
Exactmer develops and manufactures PLIMs (Polymer Membranes with Locked Intrinsic Microporosity), ultrathin polymer membranes for rapidly and selectively separating complex hydrocarbon mixtures as an energy-efficient alternative to thermal distillation in crude oil refining. The company is also industrializing high-purity bio-based solvents for pharmaceutical medicines manufacturing through a consortium-led program targeting substantial greenhouse gas emission reductions.
Is Exactmer a public or private company?
Exactmer is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Exactmer founded?
Exactmer was founded in 2018. It employs 11 to 50 people.
Where is Exactmer based?
Exactmer is headquartered in Dagenham, United Kingdom, in the Europe region.
How does Exactmer make money?
Two revenue lines are on record. Membrane Technology Licensing is the primary driver. The others are bio-based Solvents Technology.
Who are Exactmer's main competitors?
Emerging players on record are Porifera and Compact Membrane Systems. Membrane Technology and Research (MTR) is listed as a direct peer. Broad incumbents are Pall Corporation, Honeywell UOP, Evonik Industries, BASF, Solvay, Axens and DuPont.
Does Exactmer have an API?
No public API is recorded for Exactmer.
What industry is Exactmer in?
Exactmer's product category is Industrial Membrane Technology. Its primary akta.pro industry code is IMAEAAAE, Bulk Industrial Solvents, with a secondary code of IMAMALAC, Bio-based Polymers & Resins (PLA, PHA, bio-PE, bio-PET, cellulose acetate). Its NAICS code is 325 and its SIC code is 2860.